Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (11-20 of 292) with videos related to

Pageof 30
Sort By:
Drug Design, Development and Therapy|December 2, 2020
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male SubjectsHyounggyoon Yoo, Yun Kim, In-Jin Jang, et al.
Clinical Drug Investigation|February 5, 2017
Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male VolunteersSang-In Park, JaeWoo Kim, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetesSuhrin Lee, SeungHwan Lee, In-Jin Jang, et al.
Drug Design, Development and Therapy|February 4, 2020
A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy SubjectsEunwoo Kim, Kyoung Ryun Park, In-Jin Jang, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With HypertensionHoward Lee, In-Jin Jang, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labelsDeok Yong Yoon, Soyoung Lee, Mu Seong Ban, et al.
Regulatory Toxicology and Pharmacology : RTP|September 7, 2012
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in KoreaAnthony R Tricker, In-Jin Jang, Claire Martin Leroy, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 27, 2026
Population Pharmacokinetic-Pharmacodynamic Analysis of Zolpidem in Healthy Volunteers: Covariate Contributions to Variability in CNS ResponsesHyun Chul Kim, Jung Sunwoo, Seonghae Yoon, et al.
Theoretical Biology & Medical Modelling|March 28, 2007
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsMichaela Vossen, Michael Sevestre, Christoph Niederalt, et al.
Translational and Clinical Pharmacology|February 26, 2020
A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studiesInbum Chung, Jaeseong Oh, SeungHwan Lee, et al.
Pageof 30

Showing results (11-20 of 292) with videos related to

Sort By:
Pageof 30
Drug Design, Development and Therapy|December 2, 2020
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male SubjectsHyounggyoon Yoo, Yun Kim, In-Jin Jang, et al.
Clinical Drug Investigation|February 5, 2017
Changes in Cardiac Function After a Single Intravenous Administration of CKD-712 in Healthy Male VolunteersSang-In Park, JaeWoo Kim, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetesSuhrin Lee, SeungHwan Lee, In-Jin Jang, et al.
Drug Design, Development and Therapy|February 4, 2020
A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy SubjectsEunwoo Kim, Kyoung Ryun Park, In-Jin Jang, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With HypertensionHoward Lee, In-Jin Jang, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|January 11, 2021
Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labelsDeok Yong Yoon, Soyoung Lee, Mu Seong Ban, et al.
Regulatory Toxicology and Pharmacology : RTP|September 7, 2012
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in KoreaAnthony R Tricker, In-Jin Jang, Claire Martin Leroy, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 27, 2026
Population Pharmacokinetic-Pharmacodynamic Analysis of Zolpidem in Healthy Volunteers: Covariate Contributions to Variability in CNS ResponsesHyun Chul Kim, Jung Sunwoo, Seonghae Yoon, et al.
Theoretical Biology & Medical Modelling|March 28, 2007
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsMichaela Vossen, Michael Sevestre, Christoph Niederalt, et al.
Translational and Clinical Pharmacology|February 26, 2020
A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studiesInbum Chung, Jaeseong Oh, SeungHwan Lee, et al.
Pageof 30